(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA |
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA |
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)? | No |
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |
(b) If answer to above question is No, please explain the reason for not complying. | |
Related party transactions |
| Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. |
Sr No. | Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes |
Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
1 | MEDI-CAPS LIMITED | AABCM1905G | MR. HEMANT SETHI | CJQPS4931M | CFO OF MEDI-CAPS LIMITED | Remuneration | | 5.6 | APPROVED BY AUDIT COMMITTEE | 5.6 | 0.9 | 1.1 | | | | | | | | | | Textual Information(1) |
2 | MEDI-CAPS LIMITED | AABCM1905G | MR. ABHISHEK JAIN | BYWPK5427J | COMPANY SECRETARY & COMPLIANCE OFFICER OF MEDI-CAPS LIMITED | Remuneration | | 2.37 | APPROVED BY AUDIT COMMITTEE | 2.37 | 0.34 | 0.4 | | | | | | | | | | Textual Information(2) |
3 | MEDI-CAPS LIMITED | AABCM1905G | MEDGEL PRIVATE LIMITED | AAECM9146J | WHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITED | Sale of goods or services | | 0.29 | APPROVED BY AUDIT COMMITTEE | 0.29 | 0 | 0 | | | | | | | | | | Textual Information(3) |
4 | MEDI-CAPS LIMITED | AABCM1905G | MEDICAPS CHARITABLE TRUST | AABTM1123F | ENTITY OVER WHICH DIRECTOR HAVE SIGNIFICANT INFLUENCE | Any other transaction | RENT RECEIVED | 3 | APPROVED BY AUDIT COMMITTEE | 3 | 0.5 | 0.5 | | | | | | | | | | Textual Information(4) |
5 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. ALOK K. GARG | AAHPG5352J | PROMOTER AND KMP(MD) OF MEDI-CAPS LIMITED AND MEDGEL PRIVATE LIMITED | Remuneration | | 36 | APPROVED BY AUDIT COMMITTEE | 36 | 6 | 6 | | | | | | | | | | Textual Information(5) |
6 | MEDGEL PRIVATE LIMITED | AAECM9146J | MRS. MANISHA GARG | ADOPG7990A | PERSON BELONGING TO PROMOTER GROUP AND KMP (WTD) OF MEDGEL PRIVATE LIMITED | Remuneration | | 18 | APPROVED BY AUDIT COMMITTEE | 18 | 3 | 3 | | | | | | | | | | Textual Information(6) |
7 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. AKSHIT GARG | BSJPG4756K | NON-EXECUTIVE DIRECTOR OF MEDI-CAPS LIMITED AND WTD OF MEDGEL PRIVATE LIMITED | Remuneration | | 18 | APPROVED BY AUDIT COMMITTEE | 18 | 3 | 3 | | | | | | | | | | Textual Information(7) |
8 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. PRAVEEN NALWAYA | ACZPN7157N | KMP(WTD) OF MEDGEL PRIVATE LIMITED | Remuneration | | 27.75 | APPROVED BY AUDIT COMMITTEE | 27.75 | 4.63 | 4.63 | | | | | | | | | | Textual Information(8) |
9 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. LOKESH PARMAR | BMSPP3821P | CFO OF MEDGEL PRIVATE LIMITED | Remuneration | | 3.35 | APPROVED BY AUDIT COMMITTEE | 3.35 | 0.56 | 0.56 | | | | | | | | | | Textual Information(9) |
10 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. PRAKHAR DUBEY | GALPD0898E | COMPANY SECRETARY OF MEDGEL PRIVATE LIMITED | Remuneration | | 0.8 | APPROVED BY AUDIT COMMITTEE | 0.8 | 0 | 0.28 | | | | | | | | | | Textual Information(10) |
11 | MEDGEL PRIVATE LIMITED | AAECM9146J | MRS. SANDHYA NALWAYA | AAOPN9487C | MANAGER AND RELATIVE OF KMP(WTD) OF MEDGEL PRIVATE LIMITED | Remuneration | | 8.96 | APPROVED BY AUDIT COMMITTEE | 8.96 | 1.49 | 1.49 | | | | | | | | | | Textual Information(11) |
12 | MEDGEL PRIVATE LIMITED | AAECM9146J | MR. PALASH GARG | CQIPG1108H | VICE PRESIDENT AND RELATIVE OF MD AND WTD OF MEDGEL PRIVATE LIMITED | Remuneration | | 1.5 | APPROVED BY AUDIT COMMITTEE | 1.5 | 0 | 0.5 | | | | | | | | | | Textual Information(12) |
13 | MEDGEL PRIVATE LIMITED | AAECM9146J | MRS. SALONI GARG | AFUPA8271L | GENERAL MANAGER AND RELATIVE OF MD AND WTD OF MEDGEL PRIVATE LIMITED | Remuneration | | 4.56 | APPROVED BY AUDIT COMMITTEE | 4.56 | 0 | 2.5 | | | | | | | | | | Textual Information(13) |
14 | MEDI-CAPS LIMITED | AABCM1905G | MEDGEL PRIVATE LIMITED | AAECM9146J | WHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITED | Investment | | | APPROVED BY AUDIT COMMITTEE | 0 | 4282.35 | 4282.35 | | | | | | | | | | Textual Information(14) |
15 | MEDI-CAPS LIMITED | AABCM1905G | MEDGEL PRIVATE LIMITED | AAECM9146J | WHOLLY OWNED SUBISIDIARY OF MEDI-CAPS LIMITED | Any other transaction | CORPORATE GUARANTEE PROVIDED | | APPROVED BY AUDIT COMMITTEE | 0 | 200 | 200 | | | | | | | | | | Textual Information(15) |
Total value of transaction during the reporting period | | | | | | | | | | 130.18 | | | | | | | | | | | | |